Title : Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.

Pub. Date : 2015 May

PMID : 25804925






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This study investigates whether increasing cerebral tissue PO2 through normobaric hyperoxia (NBO) treatment will slow the progression of BBB damage and, thus, improve the outcome of delayed tPA treatment after cerebral ischemia. PO-2 plasminogen activator, tissue type Rattus norvegicus